AN2 Therapeutics, Inc. (ANTX)
NASDAQ: ANTX · IEX Real-Time Price · USD
2.680
+0.040 (1.52%)
At close: Jul 26, 2024, 4:00 PM
2.660
-0.020 (-0.75%)
After-hours: Jul 26, 2024, 6:47 PM EDT
AN2 Therapeutics Market Cap
AN2 Therapeutics has a market cap or net worth of $79.94 million as of July 26, 2024. Its market cap has decreased by -48.69% in one year.
Market Cap
79.94M
Enterprise Value
-35.61M
1-Year Change
-48.69%
Ranking
Category
Stock Price
$2.68
Market Cap Chart
Since the IPO on March 25, 2022, AN2 Therapeutics's market cap has decreased from $281.10M to $79.94M, a decrease of -71.56%. That is a compound annual growth rate of -41.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 25, 2024 | 78.70M | -87.09% |
| Dec 29, 2023 | 609.40M | 229.58% |
| Dec 30, 2022 | 184.90M | -34.22% |
| Mar 25, 2022 | 281.10M | - |
View and export this data all the way back to 2022.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Monogram Orthopaedics | 79.49M |
| Milestone Pharmaceuticals | 79.37M |
| Chimerix | 79.35M |
| Oncolytics Biotech | 78.89M |
| SCYNEXIS | 78.77M |
| Genenta Science | 78.33M |
| Forian | 77.85M |
| Marinus Pharmaceuticals | 77.73M |